跳至主要内容
临床试验/JPRN-UMIN000019118
JPRN-UMIN000019118招募中未知

Efficacy and safety of inhaled formoterol in Japanese COPD patients with %FEV1>=80% - Efficacy and safety of inhaled formoterol in Japanese COPD patients with %FEV1>=80%

Kanazawa University Hospital0 个研究点目标入组 30 人开始时间: 2015年9月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Key exclusion criteria ware: a history or current clinical diagnosis of asthma or atopic disease such as allergic rhinitis; positive to specific IgE for environmental allergens; positive results of a methacholine inhalation challenge (<10,000 micro g/ml); use of long acting beta2-aganist, long acting muscarinic antagonist, theophylline, inhaled/oral/intravenous steroid, leukotriene receptor antagonist; sensitivity to the study drug; poor inhalation technique of the study drug; exhaled nitric oxide over 22 ppb in ex smoker or 18 ppb in current smoker (NIOX MINO); respiratory infection or respiratory tract disorder other than COPD; unstable ischemic heart disease or any other relevant cardiovascular disorder; women of childbearing potential or of breast-feeding; mental disorder or psychiatric symptom; several medical conditions prohibiting partitipation

研究者

相似试验